OraLiva awarded $1.9M National Institute of Dental and Craniofacial Research (NIDCR at NIH) Direct to Phase II SBIR grant for AI-linked cytomics-on-a-chip Read More
Provider Login

OraLiva for DSOs

Standardize Early Detection Across Your Network

Built for Scale.
Designed for Consistency.

With a painless chairside test, AI-powered cytology, and consistent reporting, OraLiva brings early detection into every practice, without disrupting patient flow or creating administrative burden
  • No scalpel or anesthesia.
  • Billlable procedure with broad coverage.
  • Risk-stratified reports that support timely clinical decisions.

OraLiva Across Multi-Practice Settings

OraLiva fits naturally into DSO environments, helping providers deliver preventive care with efficiency, clarity, and confidence.

1

Chairside Sample
Collection

OraLiva’s soft brush allows providers to collect cells quickly and comfortably during routine exams. No scalpel, anesthesia, or lab shipping required.

2

Centralized AI
Analysis

Samples are analyzed through OraLiva’s ONC In-CYT platform. AI trained on over 13 million cells delivers consistent, risk-scored results, backed by clinical validation.

3

Results Within 1–2
Weeks

Practices receive digital reports via a secure portal, enabling timely decisions, simplified workflows, and reliable care at scale.

Why DSOs Choose OraLiva

DSOs choose OraLiva because it delivers consistent, scalable cancer screening across every practice, without complicating operations.
The procedure is simple to train, easy to delegate, and comfortable for patients. Results are returned quickly, with risk scoring that supports clear decision-making and documentation. It’s a reliable way to standardize care, support early detection, and reduce liability across the network.
  • System-Wide Consistency
    Standardized screening protocol across all locations
  • Reimbursable Service
    Eligible under CDT D7288 and CPT 88112
  • Efficient Implementation
    Minimal training required for clinical staff
  • Improved Preventive Care
    Supports early detection and proactive treatment
  • Reduced Risk Exposure
    Objective reporting helps mitigate missed diagnoses
  • Faster Clinical Decisions
    Actionable results delivered within 1–2 weeks

Get Started Today

Interested in using OraLiva in your practice? Complete the form and our team will reach out with details..

Stay Informed on the Future of Oral Cancer Detection

Join the OraLiva wait list for product launch news and insights designed to support your team and improve early cancer detection in everyday care.

Get exclusive early access.

Join OraLiva's Waitlist